Texas Health Harris Methodist Hospital Fort Worth is ranked among the most active U.S. sites in a global trial of a new defibrillator for life-threatening heart rhythm disorders.
The UNT Health Science Center at Fort Worth is hosting the Women’s Cardiovascular and Brain Health Symposium February 1 and 2. The event will be "a transformative event for our research and health communities," says HSC's Dr. Mark Cunningham, bringing together scientists and community members to discuss the latest research on women’s cardiovascular and brain health topics.
UT Arlington principal investigator Dr. Suvra Pal said that previous studies modeling the probability of a cancer cure—also called the cure rate—"used a generalized linear model." The new statistical modeling method published by Pal and his student is said to be 30% more effective in predicting who will be cured of cancer and who will need further treatment.
Southlake-based HeartSciences, which closed on a $6.375M IPO in June, applies AI-based technology to an ECG to detect cardiac dysfunction—one of the earliest signs of heart disease. The company says this can't be diagnosed by current conventional ECGs, making its MyoVista Wavelet ECG device a potential game changer.
CEO Andrew Simpson says adding this diagnostic information to an ECG "addresses a significant unmet need in the market with an estimated 100 million-plus ECG tests performed annually in the U.S.A. alone."
Also, a collaborative study looks at how important exercise is to good health for those diagnosed with depression. Here are some of the research projects underway in North Texas aimed at making our lives better.
Coronary microvascular dysfunction is a disease that affects the walls and inner linings of tiny coronary artery blood vessels that branch off from larger coronary arteries.
Ireland-based H&MV Engineering planted its North American headquarters in Dallas. The move is part of a push to create 1,000 new U.S. jobs and reach $3.5 billion in revenue over the next five years....
The Colossal Foundation and the IUCN Species Survival Commission launched a four-year, $4 million partnership to accelerate species conservation. The foundation is the nonprofit arm of Dallas-based de-extinction company Colossal Biosciences....
Ireland-based H&MV Engineering planted its North American headquarters in Dallas. The move is part of a push to create 1,000 new U.S. jobs and reach $3.5 billion in revenue over the next five years....
The Colossal Foundation and the IUCN Species Survival Commission launched a four-year, $4 million partnership to accelerate species conservation. The foundation is the nonprofit arm of Dallas-based de-extinction company Colossal Biosciences....